NEVVI Medicare utilization intelligence
or

← back

Provider profile

STEPHENS, NICOLE APRN

Nurse Practitioner · NPI 1811580913 · OCALA, FL

1
Groups
28
Codes · 2024
52,675
Disclosed services

STEPHENS, NICOLE is a Nurse Practitioner in OCALA, FL, a member of 1 medical group, who billed 28 distinct codes to Medicare Part B in 2024.

Groups: OCALA ONCOLOGY CENTER PL (OCALA, FL)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒

Provider overview · all codes · CY2024

52,675
disclosed services
28
codes billed to Medicare Part B
Prior year · CY2023 25,772 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
Q5101 Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J9271 Injection, pembrolizumab, 1 mg
J1437 Injection, ferric derisomaltose, 10 mg
J0897 Injection, denosumab, 1 mg
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
J1626 Injection, granisetron hydrochloride, 100 mcg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
96372 Injection of drug or substance under skin or into muscle
J2469 Injection, palonosetron hcl, 25 mcg
96375 Injection of additional new drug or substance into vein
96413 Administration of chemotherapy into vein, 1 hour or less
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
J1200 Injection, diphenhydramine hcl, up to 50 mg
96360 Infusion into a vein for hydration, 31-60 minutes
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96417 Administration of additional new drug or substance into vein, 1 hour or less
96415 Administration of chemotherapy into vein, each additional hour
96523 Irrigation of implanted venous access drug delivery device
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
36591 Collection of blood sample from implanted device
99195 Drawing of blood for a medical problem

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.